Friday, 18 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14435
Articles
Company
Deals
Mindray Partners with BOMImed for Exclusive Canadian Sales and Service
January 26, 2025
Company
Deals
Simnova Partners with Orna Therapeutics for In Situ CAR Therapies
January 26, 2025
Company
Aurisco Partners with Cytiva to Build Oligonucleotide Production Plant
January 26, 2025
Company
Drug
Jiangsu Aidea’s ACC007 Approved by NMPA for HIV-1 Treatment
January 26, 2025
Company
Deals
WuXi Biologics and GSK Ink Licensing Agreement for T-Cell Engaging Antibodies
January 26, 2025
Company
Deals
Antengene Acquires Full Rights to Calithera’s CD73 Inhibitor CB-708
January 26, 2025
Company
Drug
Haisco’s EGFR-PROTAC HSK40118 Accepted for Review by China’s NMPA
January 26, 2025
Company
Deals
Duality Biologics Licenses ADC Platform to Denmark’s Adcendo for Mesenchymal Tumor Program
March 3, 2025
Policy / Regulatory
NMPA Strengthens Oversight of COVID-19 Drugs and Home Treatment Guidelines
January 26, 2025
Company
Medical Device
NMPA Approves Chinabridge’s ECMO Equipment for Emergency Use
January 26, 2025
Company
Drug
EOC Pharma’s Entinostat NDA Accepted by China’s NMPA for Breast Cancer
January 26, 2025
Company
Deals
HighTide Therapeutics Completes $107 Million Series C and C+ Financing Rounds
January 26, 2025
1
2
…
1,056
1,057
1,058
1,059
1,060
…
1,202
1,203
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?